543595 EPBIO

EP Biocomposites Share Price

₹139.00 -2.5 (-1.77%)

22 Nov, 2024 07:06

SIP TrendupStart SIP in EPBIO

Start SIP

Performance

  • Low
  • ₹0
  • High
  • ₹0
  • 52 Week Low
  • ₹0
  • 52 Week High
  • ₹0
  • Open Price₹0
  • Previous Close₹0
  • Volume0

Investment Returns

  • Over 1 Month -21.89%
  • Over 3 Month -30.52%
  • Over 6 Month + 3%
  • Over 1 Year -26.84%
SIP Lightning

Smart Investing Starts Here Start SIP with EP Biocomposites for Steady Growth!

Invest Now

EP Biocomposites Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

EP Biocomposites Financials

EP Biocomposites Technicals

EMA & SMA

Current Price
₹139.00
-2.5 (-1.77%)
pointer
  • stock-down_img
  • Bullish Moving Average 0
  • stock-up_img
  • Bearish Moving Average 16
  • 20 Day
  • ₹166.46
  • 50 Day
  • ₹170.07
  • 100 Day
  • ₹170.98
  • 200 Day
  • ₹176.36

Resistance and Support

137.37 Pivot Speed
  • R3 147.03
  • R2 143.27
  • R1 141.13
  • S1 135.23
  • S2 131.47
  • S3 129.33

What's your outlook on EP Biocomposites?

You can only vote for once

EP Biocomposites Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-11-13 Half Yearly Results
2024-05-24 Audited Results
2023-11-14 Half Yearly Results
2023-05-29 Audited Results
2022-11-12 Half Yearly Results

EP Biocomposites F&O

EP Biocomposites Shareholding Pattern

No data available.

About EP Biocomposites

  • NSE Symbol
  • EPBIO
  • BSE Symbol
  • 543595
  • ISIN
  • INE0D2I01014

Similar Stocks to EP Biocomposites

EP Biocomposites FAQs

EP Biocomposites share price is ₹139 As on 22 November, 2024 | 06:52

The Market Cap of EP Biocomposites is ₹23.4 Cr As on 22 November, 2024 | 06:52

The P/E ratio of EP Biocomposites is As on 22 November, 2024 | 06:52

The PB ratio of EP Biocomposites is 2.4 As on 22 November, 2024 | 06:52

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91
 
footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23